HLF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Herbalife Ltd (HLF) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts, such as refinancing efforts and a slight upward price movement, the weak financial performance, mixed analyst ratings, and lack of strong trading signals suggest that holding the stock and monitoring further developments is a more prudent approach.
The MACD is positive at 0.194, indicating mild bullish momentum, while the RSI at 68.92 is neutral. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting an upward trend. Key resistance levels are at 19.897 and 21.028, with support at 16.238 and 15.107. Overall, the technical indicators suggest a mild bullish trend but not a strong buy signal.
The stock has a 70% chance of gaining 1.4% in the next week and 3.26% in the next month.
Additionally, there are no significant hedge fund or insider trading trends, and no recent Congress trading data.
In Q4 2025, revenue increased by 6.26% YoY to $1.283 billion, but net income dropped by 52% YoY to $85.4 million. EPS fell by 53.45% YoY to 0.81, and gross margin slightly declined to 77.53%. The financial performance indicates revenue growth but significant profitability challenges.
Analyst ratings are mixed. Citi and Maxim have Buy ratings with price targets of $21 and $20, respectively, citing strong Q4 results and a turnaround in the business model. However, BofA maintains an Underperform rating with a price target of $9, citing weak fundamentals and limited valuation recovery prospects.
